# ZNHIT1

## Overview
ZNHIT1 is a gene that encodes the zinc finger HIT-type containing 1 protein, which is a crucial component in various cellular processes, particularly in chromatin remodeling and transcriptional regulation. The protein is characterized by its zinc finger domain, which facilitates its role in binding to DNA and interacting with other proteins. ZNHIT1 is involved in maintaining the quiescence of hematopoietic stem cells and the self-renewal of intestinal stem cells, highlighting its importance in stem cell biology (Zhao2019Znhit1; Sun2020Chromatin). Additionally, it plays a significant role in cell cycle regulation and neuronal protection, particularly in the context of neurodegenerative diseases such as Parkinson's disease (McCarthy2022Gene). The protein's interactions with chromatin remodeling complexes and histone deacetylases underscore its multifaceted role in gene expression regulation (McCarthy2022Gene). Alterations in ZNHIT1 expression have been linked to various pathological conditions, including hematological disorders and cancers, further emphasizing its clinical significance (Sun2020Chromatin; Ebeid2022Znhit1).

## Function
ZNHIT1 is a zinc finger protein involved in chromatin remodeling and transcriptional regulation. It plays a crucial role in maintaining hematopoietic stem cell (HSC) quiescence by regulating the transcription of genes such as Egr1, Klf4, and Pten, and by restricting PI3K-Akt signaling, which is important for cell cycle regulation. This function is essential for preventing stem cell exhaustion and maintaining long-term HSC function (Sun2020Chromatin).

In the context of intestinal stem cells, ZNHIT1 is vital for the self-renewal of Lgr5+ intestinal stem cells by promoting the incorporation of the histone variant H2A.Z into transcription start sites of key genes. This process is necessary for the transcriptional regulation of genes involved in stem cell maintenance and differentiation (Zhao2019Znhit1).

ZNHIT1 also plays a role in cell cycle regulation by inducing G1-phase arrest through the down-regulation of cyclin-dependent kinase 6 (CDK6) expression. This is achieved via transcriptional repression, potentially linked to decreased acetylation of histone H4 at the CDK6 promoter (Yang2009Znhit1).

In neuronal cells, ZNHIT1 is associated with the regulation of mitochondrial function and neurite growth, offering protection against α-synuclein-induced impairments, which are relevant in the context of Parkinson's disease (McCarthy2022Gene).

## Clinical Significance
Alterations in the expression of the ZNHIT1 gene have been implicated in several diseases. In hematological contexts, ZNHIT1 is crucial for maintaining hematopoietic stem cell (HSC) quiescence. Its deletion leads to increased myeloid cell proliferation and a myeloproliferative disorder-like condition, characterized by splenomegaly and disorganized splenic structure. This is due to the disruption of the ZNHIT1-PTEN-PI3K-Akt signaling axis, which is essential for regulating HSC quiescence and myeloid expansion (Sun2020Chromatin). In acute myeloid leukemia (AML), ZNHIT1 expression is significantly downregulated, correlating with poorer patient survival, suggesting that its loss may be a risk factor for AML (Sun2020Chromatin).

In breast cancer, ZNHIT1 expression is significantly lower in cancerous tissues compared to normal tissues. This downregulation is associated with advanced clinical stages and increased β-catenin levels, potentially contributing to tumor progression and the maintenance of cancer stem cell properties (Ebeid2022Znhit1). The repression of ZNHIT1 may activate the PI3K/Akt and Wnt/β-catenin signaling pathways, promoting cancer cell stemness and progression (Ebeid2022Znhit1).

In the context of neurodegenerative diseases, ZNHIT1 has been shown to protect against α-synuclein-induced impairments in neurite growth and mitochondrial dysfunction, which are relevant to Parkinson's disease. Overexpression of ZNHIT1 in cellular models mitigates these impairments, suggesting a protective role against neurodegenerative processes (McCarthy2022Gene).

## Interactions
ZNHIT1 is a component of the SRCAP chromatin remodeling complex, which is involved in the incorporation of the histone variant H2A.Z into chromatin. This interaction is crucial for chromatin remodeling and gene transcription regulation (Zhao2019Znhit1; McCarthy2022Gene). ZNHIT1 promotes the interaction between H2A.Z and its chaperone YL1, a process essential for the transcriptional regulation of genes involved in stem cell maintenance and differentiation (Zhao2019Znhit1). 

In the context of Parkinson's disease, ZNHIT1 is co-expressed with SNCA, the gene encoding α-synuclein, and is involved in protecting against α-synuclein-induced impairments in neurite growth and mitochondrial dysfunction. ZNHIT1 overexpression increases the incorporation of H2A.Z in SH-SY5Y cells, even when co-expressed with α-synuclein, suggesting a protective role against α-synuclein-induced cellular dysfunction (McCarthy2022Gene). 

ZNHIT1 also interacts with components of the histone deacetylase complex, including HDAC5 and HDAC6, which are associated with chromatin remodeling and transcriptional regulation (McCarthy2022Gene). These interactions highlight ZNHIT1's role in modulating chromatin structure and influencing gene expression.


## References


[1. (McCarthy2022Gene) Erin McCarthy, Aaron Barron, Noelia Morales-Prieto, Martina Mazzocchi, Cathal M. McCarthy, Louise M. Collins, Aideen M. Sullivan, and Gerard W. O’Keeffe. Gene co-expression analysis of the human substantia nigra identifies znhit1 as an snca co-expressed gene that protects against α-synuclein-induced impairments in neurite growth and mitochondrial dysfunction in sh-sy5y cells. Molecular Neurobiology, 59(5):2745–2757, February 2022. URL: http://dx.doi.org/10.1007/s12035-022-02768-9, doi:10.1007/s12035-022-02768-9. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-022-02768-9)

[2. (Ebeid2022Znhit1) Samia A. Ebeid, Nadia A. Abd El Moneim, Sanaa A. El-Benhawy, Rabie Ramadan, and Samah E. Ismail. Znhit1 and hif-2α are correlated with cancer stem cell markers in breast cancer patients. Scientific Reports, August 2022. URL: http://dx.doi.org/10.1038/s41598-022-18133-8, doi:10.1038/s41598-022-18133-8. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-18133-8)

[3. (Yang2009Znhit1) Zhengmin Yang, Yonghao Cao, Xiaoyan Zhu, Ying Huang, Yuqiang Ding, and Xiaolong Liu. Znhit1 causes cell cycle arrest and down-regulates cdk6 expression. Biochemical and Biophysical Research Communications, 386(1):146–152, August 2009. URL: http://dx.doi.org/10.1016/j.bbrc.2009.05.139, doi:10.1016/j.bbrc.2009.05.139. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.05.139)

[4. (Zhao2019Znhit1) Bing Zhao, Ying Chen, Ning Jiang, Li Yang, Shenfei Sun, Yan Zhang, Zengqi Wen, Lorraine Ray, Han Liu, Guoli Hou, and Xinhua Lin. Znhit1 controls intestinal stem cell maintenance by regulating h2a.z incorporation. Nature Communications, March 2019. URL: http://dx.doi.org/10.1038/s41467-019-09060-w, doi:10.1038/s41467-019-09060-w. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-09060-w)

[5. (Sun2020Chromatin) Shenfei Sun, Ning Jiang, Yamei Jiang, Qiuping He, Hua He, Xin Wang, Li Yang, Runsheng Li, Feng Liu, Xinhua Lin, and Bing Zhao. Chromatin remodeler znhit1 preserves hematopoietic stem cell quiescence by determining the accessibility of distal enhancers. Leukemia, 34(12):3348–3358, July 2020. URL: http://dx.doi.org/10.1038/s41375-020-0988-5, doi:10.1038/s41375-020-0988-5. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41375-020-0988-5)